Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache

Completed · Not applicable

Conditions studied: Headache, Migraine

In brief

Objective: To determine if lower paracervical intramuscular ropivacaine injection is an effective treatment for pediatric headache in an emergency department setting.

Key facts

Study ID

NCT00680823

Run by

Robert Hickey

People needed

150

Starts

2009-01-01

Expected to finish

2016-06-01

Last updated by the study team

2018-02-26

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Chief complaint of headache
• Age 7-17 years

You may not qualify if…

• Presence of fever
• meningismus
• headache that wakes the child at night
• known organic brain disease, mass, or tumor
• history of stroke
• history of allergy to ropivacaine or other aminoacyl local anesthetics
• history of liver disease
• history of impaired cardiac function
• abnormal neurologic signs
• a focal neurologic abnormality on exam that is not a known component of the child's headache syndrome
• cognitive inability to communicate the intensity of pain.
• history of shunt or other intracranial hardware

Where it is running

• Children's Hospital of Pittsburgh — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.